Calendar

Financial releases

Date Title  
Toggle Summary AbbVie to Host Fourth-Quarter 2016 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 10, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its Fourth-Quarter 2016 financial results on Friday, January 27, 2017 . AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie to Present at the 35th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Dec. 22, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 35 th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 11, 2017 . Richard A. Gonzalez , chairman and chief executive officer, will present at 10 a.m. Central time .
Toggle Summary AbbVie Announces European Fixed Income Investor Meetings
NORTH CHICAGO, Ill. , Nov. 2, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has mandated Barclays , BofA Merrill Lynch, Deutsche Bank , J.P. Morgan and Morgan Stanley (Global Coordinator) to organize a series of European fixed income investor meetings, commencing on Wednesday,
Toggle Summary AbbVie to Present at the 25th Annual Credit Suisse Healthcare Conference
NORTH CHICAGO, Ill. , Oct. 31, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 25 th Annual Credit Suisse Healthcare Conference on Tuesday, November 8, 2016 . Richard Gonzalez , chairman of the board and chief executive officer, will participate in a question and answer session at
Toggle Summary AbbVie Increases Quarterly Dividend by 12.3 Percent
NORTH CHICAGO, Ill. , Oct. 28, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) increased the company's quarterly cash dividend by 12.3 percent from $0.57 per share to $0.64 per share.  The cash dividend is payable February 15, 2017 to stockholders of record at the close of
Toggle Summary AbbVie Reports Third-Quarter 2016 Financial Results
- Reports Third-Quarter Diluted EPS of $0.97 on a GAAP Basis; Adjusted Diluted EPS of $1.21, Reflecting Growth of 7.1 Percent Over Third-Quarter 2015 - Delivers Third-Quarter Net Revenues of $6.43 Billion on a GAAP Basis; Adjusted Net Revenues Grew 8.0 Percent on an Operational Basis - Revenue
Toggle Summary AbbVie to Host Third-Quarter Earnings Conference Call
NORTH CHICAGO, Ill. , Oct. 10, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2016 financial results on Friday, October 28, 2016 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 9, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.57 per share.  The cash dividend is payable Nov. 15, 2016 to stockholders of record at the close of business on Oct. 14, 2016 .
Toggle Summary AbbVie to Present at the Morgan Stanley Global Healthcare Conference
NORTH CHICAGO, Ill. , Aug. 30, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 14, 2016 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at 10:40
Toggle Summary AbbVie Reports Second-Quarter 2016 Financial Results
- Reports Second-Quarter Diluted EPS of $0.98 on GAAP Basis; Adjusted Diluted EPS of $1.26, Reflecting Growth of 16.7 Percent Over Second-Quarter 2015 - Delivers Second-Quarter Net Revenues of $6.45 Billion; $6.43 Billion on Adjusted Basis, Reflecting an 18.0 Percent Increase Operationally -